Comparison of two natural surfactants for pulmonary hemorrhage in very low-birth-weight infants: A randomized controlled trial

American Journal of Perinatology

Volumn 32, Issue 3, 2015, Pages 211-218

  Bozdaʇ, Şenol ^a   Dilli, Dilek ^b   Gökmen, Tülin ^a   Dilmen, Uʇur ^c,d  

^a Department of Neonatology Umraniye Research and Training Hospital ^*  (Turkey)

^b Dr Sami Ulus Maternity and Children Training and Research Hospital   (Turkey)

^c Zekai Tahir Burak Maternity Teaching Hospital   (Turkey)

^d YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

Author keywords

premature; pulmonary hemorrhage; surfactant

Indexed keywords

BERACTANT; PORACTANT; BIOLOGICAL PRODUCT; PHOSPHOLIPID; SURFACTANT;

ADULT; ARTICLE; BIRTH WEIGHT; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HUMAN; LUNG DYSPLASIA; LUNG HEMORRHAGE; MALE; MORTALITY; NEWBORN; OXYGENATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; VERY LOW BIRTH WEIGHT; COMPARATIVE STUDY; HEMORRHAGE; NEONATAL RESPIRATORY DISTRESS SYNDROME; PREMATURITY;

BIOLOGICAL PRODUCTS; BIRTH WEIGHT; BRONCHOPULMONARY DYSPLASIA; FEMALE; GESTATIONAL AGE; HEMORRHAGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SURFACE-ACTIVE AGENTS;

EID: 84923696284     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0034-1389090     Document Type: Article

References (21)

1. Raju T. NK, Langenberg P. Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis. J Pediatr: 1993; 123 4 603 610
2. Pandit P. B., Dunn M. S., Colucci E. A. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pediatrics: 1995; 95 1 32 36
3. Trompeter R., Yu V. YH, Aynsley-Green A., Roberton N. RC. Massive pulmonary haemorrhage in the newborn infant. Arch Dis Child: 1975; 50 2 123 127
4. Horbar J. D., Wright L. L., Soll R. F., et al. National Institute of Child Health and Human Development Neonatal Research Network. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr: 1993; 123 5 757 766
5. Holm B. A., Notter R. H. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. J Appl Physiol: 1987; 63 4 1434 1442
6. Jobe A. H. Pulmonary surfactant therapy. N Engl J Med: 1993; 328 12 861 868
7. Speer C. P., Robertson B., Curstedt T., et al. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics: 1992; 89 1 13 20
8. Ramanathan R. Choosing a right surfactant for respiratory distress syndrome treatment. Neonatology: 2009; 95 1 1 5
9. Tomaszewska M., Stork E., Minich N. M., Friedman H., Berlin S., Hack M. Pulmonary hemorrhage: clinical course and outcomes among very low-birth-weight infants. Arch Pediatr Adolesc Med: 1999; 153 7 715 721
10. Amizuka T., Shimizu H., Niida Y., Ogawa Y. Surfactant therapy in neonates with respiratory failure due to haemorrhagic pulmonary oedema. Eur J Pediatr: 2003; 162 10 697 702
11. Pandit P. B., O'Brien K., Asztalos E., Colucci E., Dunn M. S. Outcome following pulmonary haemorrhage in very low birthweight neonates treated with surfactant. Arch Dis Child Fetal Neonatal Ed: 1999; 81 1 F40 F44
12. Ortiz R. M., Cilley R. E., Bartlett R. H. Extracorporeal membrane oxygenation in pediatric respiratory failure. Pediatr Clin North Am: 1987; 34 1 39 46
13. Papile L. A., Burstein J., Burstein R., Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr: 1978; 92 4 529 534
14. Walsh M. C., Kliegman R. M. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am: 1986; 33 1 179 201
15. Northway W. H. Jr. Observations on bronchopulmonary dysplasia. J Pediatr: 1979; 95 5 Pt 2 815 818
16. An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity. [No authors listed]. Arch Ophthalmol.: 1984; 102 8 1130 1134
17. Alfaleh K., Smyth J. A., Roberts R. S., Solimano A., Asztalos E. V., Schmidt B.; Trial of Indomethacin Prophylaxis in Preterms Investigators. Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. Pediatrics: 2008; 121 2 e233 e238
18. Strauss T., Rozenzweig N., Rosenberg N., et al. Surfactant impairs coagulation in-vitro: a risk factor for pulmonary hemorrhage? Thromb Res: 2013; 132 5 599 603
19. Rogers D. Pulmonary haemorrhage, surfactant, and low-birthweight babies. Lancet: 1993; 341 8846 698
20. Li L., Yu J., Wang J., et al. A prediction score model for risk factors of mortality in neonate with pulmonary hemorrhage: the experience of single neonatal intensive care unit in Southwest China. Pediatr Pulmonol: 2008; 43 10 997 1003
21. Lin T. W., Su B. H., Lin H. C., et al. Risk factors of pulmonary hemorrhage in very-low-birth-weight infants: a two-year retrospective study. Acta Paediatr Taiwan: 2000; 41 5 255 258